{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:27:35Z","timestamp":1733876855467,"version":"3.30.1"},"reference-count":33,"publisher":"Medknow","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/jcrt.jcrt_132_17","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T05:56:03Z","timestamp":1505282163000},"page":"676","source":"Crossref","is-referenced-by-count":8,"title":["MicroRNA-30c inhibits metastasis of ovarian cancer by targeting metastasis-associated gene 1"],"prefix":"10.4103","volume":"13","author":[{"given":"Di","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Ping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/0973-1482.214461-1","first-page":"1376","volume-title":"Ovarian cancer","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"key-10.4103\/0973-1482.214461-2","doi-asserted-by":"crossref","unstructured":"Waldron L, Haibe-Kains B, Culhane AC, Riester M, Ding J, Wang XV, et al. Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer. J Natl Cancer Inst 2014;106. pii: Dju049.","DOI":"10.1093\/jnci\/dju049"},{"key":"key-10.4103\/0973-1482.214461-3","first-page":"498","volume-title":"SiRNA and epigenetic aberrations in ovarian cancer","author":"Mirzaei","year":"2016","journal-title":"J Cancer Res Ther"},{"key":"key-10.4103\/0973-1482.214461-4","first-page":"5150","volume-title":"New strategies in ovarian cancer: Translating the molecular complexity of ovarian cancer into treatment advances","author":"Liu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0973-1482.214461-5","first-page":"3619","volume-title":"Epithelial ovarian cancer experimental models","author":"Lengyel","year":"2014","journal-title":"Oncogene"},{"key":"key-10.4103\/0973-1482.214461-6","first-page":"257","volume-title":"Epigenetic biomarkers in epithelial ovarian cancer","author":"Gloss","year":"2014","journal-title":"Cancer Lett"},{"key":"key-10.4103\/0973-1482.214461-7","first-page":"5843","volume-title":"Improved clinical outcomes of patients with ovarian carcinoma arising in endometriosis","author":"Lu","year":"2017","journal-title":"Oncotarget"},{"key":"key-10.4103\/0973-1482.214461-8","first-page":"785","volume-title":"Novel risk models for early detection and screening of ovarian cancer","author":"Russell","year":"2017","journal-title":"Oncotarget"},{"key":"key-10.4103\/0973-1482.214461-9","first-page":"454","volume-title":"The Role of risk-reducing surgery in hereditary breast and ovarian cancer","author":"Hartmann","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-1482.214461-10","first-page":"1297","volume-title":"Non-coding RNAs in development and disease: Background, mechanisms, and therapeutic approaches","author":"Beermann","year":"2016","journal-title":"Physiol Rev"},{"key":"key-10.4103\/0973-1482.214461-11","first-page":"53","volume-title":"Role of microRNAs in maintaining cancer stem cells","author":"Garofalo","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"key-10.4103\/0973-1482.214461-12","first-page":"1070","volume-title":"The role low microRNA-335 expression in prognosis prediction of human cancers","author":"He","year":"2016","journal-title":"J Cancer Res Ther"},{"key":"key-10.4103\/0973-1482.214461-13","first-page":"421","volume-title":"Towards a molecular understanding of microRNA-mediated gene silencing","author":"Jonas","year":"2015","journal-title":"Nat Rev Genet"},{"key":"key-10.4103\/0973-1482.214461-14","first-page":"937","volume-title":"MiR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma","author":"Kim","year":"2015","journal-title":"Cancer Lett"},{"key":"key-10.4103\/0973-1482.214461-15","first-page":"25","volume-title":"MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer","author":"Sun","year":"2015","journal-title":"J Pathol"},{"key":"key-10.4103\/0973-1482.214461-16","first-page":"173","volume-title":"Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: Prognostic value and prospective role in ovarian cancer therapeutics","author":"Koutsaki","year":"2014","journal-title":"Cancer Lett"},{"key":"key-10.4103\/0973-1482.214461-17","first-page":"5063","volume-title":"The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis","author":"Bridge","year":"2012","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.214461-18","first-page":"1106","volume-title":"MicroRNA-30c-2-3p negatively regulates NF-\u03baB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer","author":"Shukla","year":"2015","journal-title":"Mol Oncol"},{"key":"key-10.4103\/0973-1482.214461-19","first-page":"807","volume-title":"MicroRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1","author":"Zhou","year":"2012","journal-title":"Oncol Rep"},{"key":"key-10.4103\/0973-1482.214461-20","first-page":"703","volume-title":"MicroRNA-30b\/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18","author":"Zhong","year":"2014","journal-title":"BMC Cancer"},{"key":"key-10.4103\/0973-1482.214461-21","first-page":"1215","volume-title":"Downregulation of miRNA-30c and miR-203a is associated with hepatitis C virus core protein-induced epithelial-mesenchymal transition in normal hepatocytes and hepatocellular carcinoma cells","author":"Liu","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"key-10.4103\/0973-1482.214461-22","first-page":"22958","volume-title":"A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines.cDNA cloning, expression, and protein analyses","author":"Toh","year":"1994","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0973-1482.214461-23","first-page":"387","volume-title":"Metastasis-associated protein 1\/nucleosome remodeling and histone deacetylase complex in cancer","author":"Li","year":"2012","journal-title":"Cancer Res"},{"key":"key-10.4103\/0973-1482.214461-24","first-page":"433","volume-title":"Overexpression of MTA1 promotes invasiveness and metastasis of ovarian cancer cells","author":"He","year":"2014","journal-title":"Ir J Med Sci"},{"key":"key-10.4103\/0973-1482.214461-25","first-page":"9","volume-title":"Metastasis-associated protein 1 expression in oral squamous cell carcinomas: Correlation with metastasis and angiogenesis","author":"Andishehtadbir","year":"2015","journal-title":"Turk Patoloji Derg"},{"key":"key-10.4103\/0973-1482.214461-26","first-page":"2779","volume-title":"MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer","author":"Ling","year":"2014","journal-title":"Mol Biol Rep"},{"key":"key-10.4103\/0973-1482.214461-27","first-page":"2575","volume-title":"Low expression of microRNA-30c promotes invasion by inducing epithelial mesenchymal transition in non-small cell lung cancer","author":"Zhong","year":"2014","journal-title":"Mol Med Rep"},{"key":"key-10.4103\/0973-1482.214461-28","first-page":"73","volume-title":"Hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV\/CCN3","author":"Dobson","year":"2014","journal-title":"Cancer Cell Int"},{"key":"key-10.4103\/0973-1482.214461-29","first-page":"973","volume-title":"A feedback loop between miR-30a\/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells","author":"Han","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"key-10.4103\/0973-1482.214461-30","first-page":"e90810","volume-title":"Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer","author":"Kong","year":"2014","journal-title":"PLoS One"},{"key":"key-10.4103\/0973-1482.214461-31","first-page":"112","volume-title":"Structure, expression and functions of MTA genes","author":"Kumar","year":"2016","journal-title":"Gene"},{"key":"key-10.4103\/0973-1482.214461-32","first-page":"1017","volume-title":"Clinical implications of MTA proteins in human cancer","author":"Kaur","year":"2014","journal-title":"Cancer Metastasis Rev"},{"key":"key-10.4103\/0973-1482.214461-33","first-page":"891","volume-title":"Properties and clinical relevance of MTA1 protein in human cancer","author":"Toh","year":"2014","journal-title":"Cancer Metastasis Rev"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T05:58:12Z","timestamp":1505282292000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cancerjournal.net\/text.asp?2017\/13\/4\/676\/214461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"alternative-id":["214461"],"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_132_17","relation":{},"ISSN":["0973-1482"],"issn-type":[{"type":"print","value":"0973-1482"}],"subject":[],"published":{"date-parts":[[2017]]}}}